Apple has successfully secured a temporary pause on the import ban imposed on its latest Apple Watch models, marking a significant victory for the tech giant. The U.S. appeals court decision allows Apple to resume selling the Apple Watch Series 9 and Ultra 2 models.

In an official statement, Apple announced that these latest models would be available in Apple stores starting Wednesday, with online sales set to commence on Thursday. An Apple spokesperson expressed excitement about reintroducing the full Apple Watch lineup to customers, specifically highlighting the inclusion of features like the blood oxygen monitor.

Last week, Apple temporarily halted sales of the Series 9 and Ultra 2 watches both in physical stores and online. This move was in response to an International Trade Commission (ITC) order from October, which ruled that the blood oxygen sensor in these devices infringed on intellectual property owned by Masimo, a medical technology company serving hospitals.

The court filing on Wednesday revealed, “The motion for an interim stay is granted to the extent that the Remedial Orders are temporarily stayed.” Despite the Biden administration declining to pause the ITC ban on Monday, Apple swiftly filed an appeal with the U.S. Court of Appeals for the Federal Circuit on Tuesday, seeking a longer stay. The ITC is expected to respond by January 10.

Apple also disclosed that it submitted redesigned Apple Watch models for customs approval, potentially mitigating the ban’s impact. This temporary reprieve allows Apple to offer its latest watch models during a crucial period, with Apple Watch sales contributing significantly to the company’s wearables business, reporting $39.8 billion in sales for fiscal 2023.

The brief sales pause did not affect the Apple Watch SE, an older model without blood oxygen level monitoring capabilities. During this period, the latest models were still available from other retailers like Best Buy and Amazon, as long as they had existing stock.

Masimo experienced a more than 4% drop in its shares following the court decision, while Apple’s stock remained unchanged.